nicotinamide mononucleotide has been researched along with Lung Injury, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, XM; Li, HR; Li, P; Liu, Q; Tian, Y; Wang, JF; Zhu, CL | 1 |
1 other study(ies) available for nicotinamide mononucleotide and Lung Injury, Acute
| Article | Year |
|---|---|
Nicotinamide Mononucleotide Attenuates LPS-Induced Acute Lung Injury With Anti-Inflammatory, Anti-Oxidative and Anti-Apoptotic Effects.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Inflammation; Interleukin-6; Lipopolysaccharides; Lung; Mice; NF-kappa B; Nicotinamide Mononucleotide; p38 Mitogen-Activated Protein Kinases; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2023 |